SCHEMBL17367159

SCHEMBL17367159

c1ccc(-n2c3ccccc3c3c4ccc5c6ccc7ccccc7c6n(-c6ccccc6)c5c4sc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
ATM Q13315 2/20 0.41
KDM4E B2RXH2 2/20 0.41
SIGMAR1 Q99720 1/20 0.33
PRNP P04156 1/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 2/20 0.32
HTT P42858 2/20 0.32
CYP3A4 P08684 2/20 0.31
HPGD P15428 2/20 0.31
TSHR P16473 2/20 0.31
CASP1 P29466 1/20 0.31
RAB9A P51151 1/20 0.31
CASP7 P55210 1/20 0.31
HIF1A Q16665 1/20 0.31
ALDH1A1 P00352 3/20 0.31
CYP1A2 P05177 1/20 0.31
GLA P06280 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367129 0.87 L3MBTL1 (0.52) L3MBTL1ATMKDM4EHSD17B10MAPK1
SCHEMBL17367156 0.87 ATM (0.39) L3MBTL1ATMKDM4ESIGMAR1HSD17B10
SCHEMBL17367036 0.86 KDM4E (0.43) L3MBTL1ATMKDM4ESIGMAR1PRNP
SCHEMBL17367160 0.85 KDM4E (0.42) L3MBTL1ATMKDM4ESIGMAR1HSD17B10
SCHEMBL17367107 0.85 KDM4E (0.41) L3MBTL1ATMKDM4ESIGMAR1HSD17B10
SCHEMBL17367117 0.85 L3MBTL1 (0.41) L3MBTL1ATMKDM4EHSD17B10HTT
SCHEMBL22650653 0.85 L3MBTL1 (0.44) L3MBTL1ATMKDM4ESIGMAR1PRNP
SCHEMBL17366879 0.84 ALDH1A1 (0.39) L3MBTL1ATMKDM4EHSD17B10MAPK1
SCHEMBL19786513 0.81 KDM4E (0.47) L3MBTL1ATMKDM4ESIGMAR1HSD17B10
SCHEMBL17367114 0.81 KDM4E (0.37) L3MBTL1ATMKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 L3MBTL1 717/4885ATM 3202/4885KDM4E 3404/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 L3MBTL1 717/4885ATM 3202/4885KDM4E 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.